Non-neutralizing functions in anti-SARS-CoV-2 IgG antibodies
Sebastian Reinig,
No information about this author
Shin‐Ru Shih
No information about this author
Biomedical Journal,
Journal Year:
2023,
Volume and Issue:
47(1), P. 100666 - 100666
Published: Sept. 29, 2023
Most
individuals
infected
with
or
vaccinated
against
COVID-19
develop
antigenic
neutralizing
immunoglobulin
G
(IgG)
antibodies
the
SARS-CoV-2
spike
protein.
Although
are
biomarkers
of
adaptive
immune
response,
their
mere
presence
is
insufficient
to
explain
protection
afforded
disease
its
pathology.
IgG
exhibits
other
secondary
effector
functions
that
activate
innate
components,
including
complement,
natural
killer
cells,
and
macrophages.
The
affinity
for
cells
depends
on
isotypes
glycosylation
antibodies.
anti-spike
titer
should
be
sufficient
provide
significant
Fc-mediated
effects
in
severe
COVID-19,
mRNA,
protein
subunit
vaccinations.
In
combination
aberrant
pro-inflammatory
afucosylated
IgG1
IgG3
may
detrimental
COVID-19.
antibody
response
mRNA
vaccines
leads
higher
fucosylation
a
less
inflammatory
profile,
long-term
shift
IgG4,
which
correlated
from
disease.
Language: Английский
Immunosuppressive Therapy Modifies Anti-Spike IgG Subclasses Distribution After Four Doses of mRNA Vaccination in a Cohort of Kidney Transplant Recipients
Vaccines,
Journal Year:
2025,
Volume and Issue:
13(2), P. 123 - 123
Published: Jan. 25, 2025
Background:
IgG4
is
the
least
immunogenic
subclass
of
IgG.
Immunization
with
mRNA
vaccines
against
SARS-CoV-2,
unlike
other
vaccines,
induces
an
increase
in
spike
protein
healthy
populations.
This
study
investigated
whether
immunosuppressive
therapy
affects
immune
response,
focusing
on
IgG
changes,
to
four
doses
vaccine
kidney
transplant
recipients
(KTRs).
Methods:
includes
146
KTRs
and
23
dialysis
patients
(DPs)
who
received
three
mRNA-1273
a
BNT162b2
booster.
We
evaluated
anti-spike
titers
subclasses,
T-CD4+
T-CD8+
cellular
responses,
serum
neutralizing
activity
(SNA).
Results:
At
fourth
dose,
75.8%
COVID-19
naïve
developed
humoral
responses
(vs.
95.7%
DPs).
There
was
correlation
between
titers/subclasses
SNA
(p
<
0.001).
kinetics
after
third/fourth
dose
differed
DPs.
Immunosuppressive
influenced
subclasses:
mTOR
inhibitors
(mTORi)
positively
IgG1
IgG3
0.05),
while
mycophenolic
acid
negatively
affected
IgG1,
IgG3,
0.05).
correlated
breakthrough
infections
KTRs.
mTORi
only
factor
associated
>
65%
[4.29
(1.21–15.17),
p
=
0.024].
Conclusions:
show
weaker
class
shift
towards
non-inflammatory
anti-S
upon
booster
doses.
subclasses
positive
are
by
immunosuppression.
Increased
protective
infection.
may
benefit
non-responding
Language: Английский
Temporal correlations between RBD-ACE2 blocking and binding antibodies to SARS-CoV-2 variants in CoronaVac-vaccinated individuals and their persistence in COVID-19 patients
Scientific Reports,
Journal Year:
2025,
Volume and Issue:
15(1)
Published: May 6, 2025
Abstract
Antibodies
play
a
crucial
role
in
protection
against
SARS-CoV-2.
Understanding
the
correlation
between
binding
and
functional
antibodies
is
essential
to
determine
whether
antibody
levels
can
reliably
predict
neutralizing
activity.
We
assessed
responses
111
individuals
vaccinated
with
inactivated
vaccine
CoronaVac
COVID-19
patients
Thailand.
Plasma
of
ACE2-blocking
targeting
receptor-binding
domain
(RBD)
SARS-Co-V2
variants
were
measured
before
vaccination
at
14
28
days
after
second
dose
using
multiplex
surrogate
virus
neutralization
test.
Anti-spike
anti-nucleocapsid
quantified
by
electrochemiluminescence
immunoassay,
anti-RBD
IgG
ELISA.
After
vaccination,
blocking,
anti-spike,
increased
but
declined
rapidly
within
month,
whereas
persisted.
Blocking
anti-spike
correlated
day
post-vaccination
not
28.
In
patients,
correlations
moderate
14,
stronger
Correlations
weaker
for
Omicron
subvariants
than
ancestral
strain
non-Omicron
variants.
The
weak
blocking
suggests
might
These
findings
highlight
temporal
nature
CoronaVac-induced
immunity
need
booster
doses
variant-adapted
vaccine.
Language: Английский
Associations between clinical data, vaccination status, antibody responses, and post-COVID-19 symptoms in Thais infected with SARS-CoV-2 Delta and Omicron variants: a 1-year follow-up study
Wathusiri Khongsiri,
No information about this author
Prapassorn Poolchanuan,
No information about this author
Adul Dulsuk
No information about this author
et al.
BMC Infectious Diseases,
Journal Year:
2024,
Volume and Issue:
24(1)
Published: Oct. 7, 2024
Severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2),
which
causes
disease
2019
(COVID-19),
led
to
a
global
pandemic
from
2020.
In
Thailand,
five
waves
of
outbreaks
were
recorded,
with
the
fourth
and
fifth
driven
by
Delta
Omicron
variants,
resulting
in
over
20,000
new
confirmed
cases
daily
at
their
peaks.
Language: Английский
Comparison of Kinetics of Antibody Avidity and IgG Subclasses’ Response in Patients with COVID-19 and Healthy Individuals Vaccinated with the BNT162B2 (Comirnaty, Pfizer/BioNTech) mRNA Vaccine
Viruses,
Journal Year:
2023,
Volume and Issue:
15(4), P. 970 - 970
Published: April 14, 2023
There
are
limited
reports
concerning
the
levels
of
antibodies
in
IgG
subclasses
and
avidity
IgG,
which
is
functional
strength
with
an
antibody
binds
to
antigen
serum
samples
obtained
at
different
times
after
infection
or
vaccination.
This
study
investigated
kinetics
response
within
IgG1-IgG4
individuals
vaccinated
BNT162B2
mRNA
vaccine
COVID-19
patients.
Serum
were
collected
from
three
doses
(Comirnaty,
Pfizer/BioNTech)
unvaccinated
revealed
that
IgG1
was
a
dominating
subclass
both
patients
individuals.
The
level
IgG4
significantly
increased
7
months
first
two
then
again
third
dose.
IgG2
IgG3
low
most
Investigating
dynamics
essential
for
understanding
mechanisms
protection
against
viral
infections,
including
COVID-19,
especially
context
immunization
innovative
vaccines
possible
future
development
application
technology.
Language: Английский
Patterns and functional consequences of antibody speciation in maternal-fetal transfer of coronavirus-specific humoral immunity
Andrew P. Hederman,
No information about this author
Hannah M. Brookes,
No information about this author
Harini Natarajan
No information about this author
et al.
medRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 13, 2024
Abstract
Maternal
antibodies
serve
as
a
temporary
form
of
inherited
immunity,
providing
humoral
protection
to
vulnerable
neonates.
Whereas
IgG
is
actively
transferred
up
concentration
gradient
via
the
neonatal
Fc
Receptor
(FcRn),
maternal
IgA
and
IgM
are
typically
excluded
from
fetal
circulation.
Further,
not
all
molecules
exhibit
same
transfer
efficiency,
being
influenced
by
subclass,
Fab
domain
glycosylation,
antigen-specificity,
temporal
dynamics
antibody
responses.
Here,
we
investigate
phenotypes
functions
cord
blood
induced
SARS-CoV-2
infection
compare
them
those
mRNA
vaccination,
focusing
on
breadth
antigen
recognition
antiviral
including
neutralization
effector
function.
While
coronavirus-specific
functional
potency
appeared
be
more
compromised
than
binding
in
both
groups,
vaccination
substantially
greater
function
did
natural
infection.
These
were
associated
with
speciation
serum
repertoires,
some
subpopulations
enriched
while
others
relatively
depleted.
Relevant
continued
populations
context
diversifying
pathogen,
was
observed
for
neutralization,
these
activities
affinity
antigen.
This
work
provides
insights
into
maternal-fetal
responses
novel
vaccines
recently
emerged
pathogen
that
likely
public
health
burden
foreseeable
future.
Language: Английский